Jusmiral Holdings Limited, a promoter of Cohance Lifesciences, has sold 3,41,48,000 equity shares of the company via an on-market sale. The sale occurred on September 18, 2025, and reduced Jusmiral Holdings’ stake in Cohance Lifesciences from 33.08% to 24.15%. The proceeds will primarily be used for part payment of borrowings.
Promoter Shareholding Update
On September 18, 2025, Jusmiral Holdings Limited executed a sale of 3,41,48,000 equity shares of Cohance Lifesciences through an on-market transaction.
Impact on Shareholding
Following this transaction, Jusmiral Holdings Limited’s stake in Cohance Lifesciences has decreased from 33.08% (or 32.75% on a fully diluted basis) to 24.15% (or 23.91% on a fully diluted basis).
Use of Proceeds
Jusmiral Holdings Limited intends to utilize the proceeds from this share sale primarily to facilitate a partial repayment of borrowings under the Notes Purchase Agreement.
Clarification on Encumbrance
It is clarified that Jusmiral Holdings Limited has not created any pledge on the equity shares of Cohance Lifesciences.
Source: BSE
